AI-generated summary
In this triple-blind clinical trial of 30 patients undergoing implant surgery, the authors compared an 830 nm low-level laser with a placebo group. They report that the laser group had less pain at several time points up to 72 hours, less facial swelling at 7 days, and better wound healing at days 3, 7 and 14, and suggest laser may be a useful complementary therapy.
- Participants
- 30
- Who or what was studied
- 30 patients aged 25 to 65 years selected for implant insertion, divided into a laser group and a placebo group
- Wavelengths
- 830 nm
- Limits stated in the abstract
- The abstract reports a small sample of 30 patients and does not describe the study's certainty or follow-up beyond 14 days.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sbmu.ac.ir.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830 nm
- Energy density (fluence)
- 5 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Wound healing, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.